Tilray | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acasti Pharma USD 20M 8.94M 2025-06
Alaunos Therapeutics USD 1.09M 592K 2024-12
Aurora Cannabis CAD 140.16M 31.45M 2025-06
Avita Medical AUD 14.05M 3.4M 2024-12
Canopy Growth CAD 126.2M 109.89M 2025-06
Cronos Group USD 794.42M 3.4M 2025-06
Dianthus Therapeutics USD 13.24M 9.56M 2025-06
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
IQVIA Holdings USD 2.04B 299M 2025-06
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Moderna USD 1.28B 344M 2025-06
Organigram Holdings 35.88M 8.42M 2025-06
Organon & Co USD 599M 52M 2025-06
Revvity USD 991.85M 145.77M 2025-06
Tectonic Therapeutic USD 287.38M 146.14M 2025-06
Tilray USD 189.7M 15.49M 2024-11
Viatris USD 566.4M 188.6M 2025-06
Xeris Pharmaceuticals USD 59.28M 12.34M 2025-06


Tilray Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.